Search clinical trials for: EB-1020 SR3

Total 4745 results

Neurovance, Inc.

Completed

A Study to Evaluate the Safety, Tolerance, and Pharmacokinetic and Pharmacodynamic Profile Of 1 SR Formulation of EB-1020

Normal, Healthy Volunteers

Australia
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial to Evaluate the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder

Adult ADHD

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial Evaluating the Efficacy, Safety, & Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

United States
Eisai Co., Ltd.

Completed

A Pharmacokinetic (PK) Study of Three Types of E0302 Sustained Release (SR) Tablets Compared With E0302 Immediate Release (IR) Tablet Under Fed Conditions in Healthy Participants

Healthy Subjects

New Zealand
Otsuka Pharmaceutical Development & Commercialization...

Recruiting

A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

Attention Deficit/Hyperactivity Disorder

United States
Euthymics BioScience, Inc.

Completed

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Major Depressive Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...

Active, not recruiting

A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD)

Attention Deficit/Hyperactivity Disorder

United States
Abeona Therapeutics, Inc

Enrolling by invitation

A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB

RDEB

United States
Peking Union Medical College Hospital

Recruiting

Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Neuroendocrine Tumors

China
University of Arkansas

Terminated

Preoperative SRS/SRT vs Postoperative SRS/SRT for Brain Metastases

Brain Metastases

United States
Ruggeri, Mirella

Recruiting

CBT-Eb Plus EMDR Versus CBT-Eb in Patients With Eating Disorders (TREAT-EMDR)

Eating Disorder

Italy
Peking Union Medical College Hospital

Recruiting

64Cu/68Ga Labelled EB-ss-CPT PET/CT Scan in Colorectal Cancer

Colorectal Cancer

China
Epibone, Inc.

Recruiting

Evaluation of EpiBone-CMF for Mandibular Ramus Reconstruction (EB-CMF)

Mandible; Deformity | Mandibular Injuries | Mandible Tumor

United States
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Recruiting

Lu177-EB-PSMA617 Radionuclide Treatment in Patients With Metastatic Castration-resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

China
Vedic Lifesciences Pvt. Ltd.

Recruiting

A Study to Evaluate the Efficacy of EB-PA on Muscle Mass and Strength in Occasional Gym Goers

Muscle Mass and Strength

India
Bonti, Inc.

Completed

Study to Evaluate EB-001 in Reducing Musculoskeletal Pain

Musculoskeletal Pain

United States
Pfizer

Completed

Study to Estimate the Relative Bioavailability Compared to Commercial Extended-release Tablet Formulation and the Effects of Food Or Sprinkling on Applesauce for Fesoterodine Sustained-release Beads-in-capsule Formulations in Healthy Adult Volunteers

Healthy

Belgium
Peking Union Medical College Hospital

Recruiting

177Lu-PSMA-EB-01 in Patients With Metastatic Castration-resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

China
Zhejiang University

Recruiting

A Study to Evaluate the Safety and Efficacy of PRRT With 177Lu-EB-FAPI in Patients With Advanced Cholopancreatic Tumors (CISPD-5)

Advanced Pancreatic Cancer and Cholangiocarcinoma

China
Sensus Healthcare

Unknown

A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Keloid Scars.

Keloid Scar
ModernaTX, Inc.

Completed

A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults

Seasonal Influenza

United States
Bonti, Inc.

Completed

Study of EB-001 in Facial Scar Reduction

Mohs Surgery

United States
Sensus Healthcare

Completed

A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC)

Non-melanoma Skin Cancer

United States
Hospital St. Joseph, Marseille, France
NOVATECH SA

Recruiting

Evaluation of the NOVATECH ® LUCIOLA TM EB Fiducial Marker During Radiotherapy Sessions in Lung Cancer Patients (LUCIOLA)

Lung Cancer

France
Yousra Hisham Abdel Fattah
Diaa Mohamed Mohasseb; Mahmoud Mohamed Hassanein; Gihan Younis El-tantawi; Aya...

Completed

Aerobic Training in Post-MI Patients With DPN

Myocardial Infarction | Diabetes Mellitus, Type 2 | Diabetic Peripheral Neuropathy
Sensus Healthcare

Unknown

Superficial Radiation Therapy (SRT) for the Treatment of Recurrent Keloid Scars

Keloid Scar

United States
The First Affiliated Hospital of Xiamen University

Recruiting

Clinical Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Various Solid Tumors

Refractory Solid Tumor

China
Peking Union Medical College Hospital
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Unknown

177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Neuroendocrine Tumors

China
Neurovance, Inc.

Completed

A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users

Healthy Volunteers | Drug Users

United States
The University of Hong Kong
Hospital Authority, Hong Kong

Recruiting

Elastic Band-Progressive Resistance Training (EB-PRT) for Sarcopenia Among Heart Failure Patients

Heart Failure

Hong Kong
Abeona Therapeutics, Inc

Recruiting

EB-101 Treatment for New and Previously Treated Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Epidermolysis Bullosa | Recessive Dystrophic Epidermolysis Bullosa | RDEB

United States
Radboud University Medical Center

Completed

HD+ I-scan Bronchoscopy Vascular Abnormalities Detection Multicenter Study (i-scan)

Lungcancer

Netherlands, Italy, Russian Federation, Spain
Merck Sharp & Dohme LLC

Completed

A Two-part Study of the Effects of MK-1029 in Allergen-Challenged Asthmatics (MK-1029-003)

Asthma
Abeona Therapeutics, Inc

Completed

Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Epidermolysis Bullosa | Recessive Dystrophic Epidermolysis Bullosa

United States
RHEACELL GmbH & Co. KG
FGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & Services

Completed

Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa

Recessive Dystrophic Epidermolysis Bullosa

United States, Austria, France, Germany, United Kingdom
Maxwell Biomedical

Recruiting

Initial Experience With Spatial Resynchronization Therapy in Patients With Atrial Fibrillation (SR-TheAF)

Atrial Fibrillation

Georgia
Peking Union Medical College Hospital

Recruiting

Therapeutic Efficiency and Response to 2.0 GBq (55mCi) 177Lu-EB-PSMA in Patients With mCRPC

Prostate Cancer

China
EyebioKorea, Inc.

Completed

Safety, Tolerability and Pharmacokinetics of EB-203 Eye Drops in Healthy Volunteers

Healthy

Korea, Republic of
Otsuka Pharmaceutical Development & Commercialization...

Terminated

A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects

Adult Attention-deficit Hyperactivity Disorder (ADHD)

Australia
The First Affiliated Hospital of Xiamen University

Recruiting

Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer

Refractory Thyroid Gland Carcinoma | Refractory Thyroid Gland Papillary Carcinoma | Refractory Thyroid Gland Follicular Carcinoma | Refractory Thyroid Gland Hurthle Cell Carcinoma

China
Centre Francois Baclesse
Association de Neuro-Oncologues d'Expression Francaise

Active, not recruiting

Stereotactic Radiotherapy in Oligometastatic Brain Disease: a Randomised Phase III Study Comparing Hypofractionated Stereotactic Radiation Therapy (3*10 Gy) to the Historical Single-dose Radiosurgery (1*20 to 25 Gy) With Medico-economic Evaluation. (OligoBM-01)

Brain Metastasis | Oligoprogression

France
Bonti, Inc.

Completed

Evaluate Safety and Efficacy of a Single Treatment Cycle of EB-001 in Subjects With Glabellar Frown Lines

Glabellar Frown Lines (GL)

United States
Peking Union Medical College Hospital

Recruiting

Diagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617

Renal Cell Carcinoma

China
Peking Union Medical College Hospital

Recruiting

Diagnosis of Metastatic Tumors on 68Ga-FAPI PET-CT and Radioligand Therapy With 177Lu-EB-FAPI

177Lu-EB-FAPI

China
Molecular Targeting Technologies, Inc.
ClinSmart

Recruiting

177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors

Neuroendocrine Tumors

United States
Boston University
National Institute of Mental Health (NIMH)

Completed

Focused Versus Enhanced Cognitive Behavioral Therapy for Treating Women With Bulimia Nervosa

Eating Disorders

United States
Global Alliance for TB Drug Development

Completed

A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults

Tuberculosis | Tuberculosis, Pulmonary

United States

3

Subscribe